Feline injection site sarcoma (FISS) is a particular form of soft tissue tumour associated to a chronic inflammatory process that probably acts a fundamental role in the tumour pathogenesis. Many analogies are observed between FISS and human nodular fasciitis (NF), a pseudosarcomatous lesion, and myxoinflammatory fibroblastic sarcoma (MFS), another characteristic soft tissues tumour of man. All these lesions are morphologically and clinically very similar, the possible causes proposed and investigated include trauma/inflammation, genetic predisposition, exposure to radiation or certain chemicals, all of which may stimulate the tissues to divide more rapidly than normal. In human cases, as recently described in cat, oncogenes, tumor suppress...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
Introduction: The nuclear factor-kB (NF-kB) transcription factors consist of dimeric proteins of the...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
Feline injection site sarcoma (FISS) is a particular form of soft tissue tumour associated to a chro...
Feline injection-site sarcoma (FISS) is a highly aggressive and malignant tumour of mesenchymal orig...
Feline injection-site sarcomas (FISS) are known since the beginning of 90s. After the first correlat...
The feline injection-site sarcoma (FIS) is a challenge for the veterinarian and the affected cat`s o...
Background: Feline Injection Site-Associated Sarcoma (FISS) is a mesenchymal neoplasia of aggressive...
Feline injection site sarcomas (FISS) are malignant neoplasms of mesenchymal origin which arise in s...
Feline injection – site sarcomas (FISS) are aggressively behaving fibrosarcomas with a rate of metas...
Feline injection site sarcoma (FISS), formerly known as Vaccine Associated Sarcoma (VAS) is a rare, ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
In cats, the most serious of adverse effects following vaccination is the occurrence of invasive sar...
Within the past two decades, feline injection-site sarcomas have been recognized as a group of invas...
The pathogenesis of feline vaccine site-associated sarcomas (VSSs) remains obscure. The low prevale...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
Introduction: The nuclear factor-kB (NF-kB) transcription factors consist of dimeric proteins of the...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
Feline injection site sarcoma (FISS) is a particular form of soft tissue tumour associated to a chro...
Feline injection-site sarcoma (FISS) is a highly aggressive and malignant tumour of mesenchymal orig...
Feline injection-site sarcomas (FISS) are known since the beginning of 90s. After the first correlat...
The feline injection-site sarcoma (FIS) is a challenge for the veterinarian and the affected cat`s o...
Background: Feline Injection Site-Associated Sarcoma (FISS) is a mesenchymal neoplasia of aggressive...
Feline injection site sarcomas (FISS) are malignant neoplasms of mesenchymal origin which arise in s...
Feline injection – site sarcomas (FISS) are aggressively behaving fibrosarcomas with a rate of metas...
Feline injection site sarcoma (FISS), formerly known as Vaccine Associated Sarcoma (VAS) is a rare, ...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
In cats, the most serious of adverse effects following vaccination is the occurrence of invasive sar...
Within the past two decades, feline injection-site sarcomas have been recognized as a group of invas...
The pathogenesis of feline vaccine site-associated sarcomas (VSSs) remains obscure. The low prevale...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...
Introduction: The nuclear factor-kB (NF-kB) transcription factors consist of dimeric proteins of the...
Feline injection site sarcomas (FISS) were first described in the early 1990s. Despite extensive res...